Stockscreener 앱 받기
475.07
0.67%
3.17
시간 외 거래:
475.07
Idexx Laboratories Inc 주식(IDXX)의 최신 뉴스
BTIG Raises Price Target on IDEXX Laboratories to $545 From $530, Maintains Buy Rating - marketscreener.com
IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $558 From $548, Maintains Overweight Rating - marketscreener.com
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript - Insider Monkey
Leerink Partners Adjusts IDEXX Laboratories Price Target to $515 From $500 - marketscreener.com
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ... - Yahoo Finance
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Market Challenges - GuruFocus
IDEXX Laboratories Reports Strong Q1 2025 Results - TipRanks
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Lab jumps after Q1 beat and guidance raise - MSN
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Following Q1 Results | IDXX Stock News - GuruFocus
IDEXX Laboratories (IDXX) Surges After Lifting 2025 Outlook on F - GuruFocus
IDEXX Laboratories stock jumps on Q1 beat (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories (IDXX) Reports Strong Start to 2025 with Reve - GuruFocus
IDEXX Laboratories Ups Profit Forecast Thanks To Pet Care Demand - Finimize
Earnings call transcript: IDEXX Labs Q1 2025 EPS beats forecast, stock surges - Investing.com
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market - TradingView
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist? - Yahoo Finance
IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics - marketscreener.com
IDEXX (IDXX) Reports Q1 Revenue Exceeding Expectations | IDXX St - GuruFocus
IDEXX Laboratories Q1 Earnings, Revenue Increase; 2025 Outlook Raised - marketscreener.com
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates - Nasdaq
Idexx: Q1 Earnings Snapshot - MySA
IDEXX Laboratories (IDXX) Surpasses Q1 Expectations with Robust Earnings - GuruFocus
IDEXX Laboratories Announces First Quarter Results | IDXX Stock News - GuruFocus
IDEXX Laboratories Q1 2025 Earnings: EPS of $2.96 Beats Estimate - GuruFocus
IDEXX Laboratories Inc Q1 Profit Advances, Beats Estimates - Nasdaq
IDEXX LABS Earnings Results: $IDXX Reports Quarterly Earnings - Nasdaq
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 EPS $2.96, vs. FactSet Est of $2.85 - marketscreener.com
IDEXX Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com South Africa
IDEXX Laboratories Announces First Quarter Results - TradingView
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss? - TradingView
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Animal Health Diagnosis Market Is Booming So Rapidly with IDEXX Laboratories, Zoetis - openPR.com
Earnings Preview: What to Expect From IDEXX Laboratories' Report - MSN
Earnings Preview: What To Expect From IDEXX Laboratories' Report - Barchart.com
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value? - simplywall.st
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
'The Nite Show with Danny Cashman' is Coming to an End - 94.9 HOM
A Look Into IDEXX Laboratories Inc's Price Over Earnings - Benzinga
IDEXX Laboratories Inc (IDXX) Shares Up 3.88% on Apr 22 - GuruFocus
Idexx Laboratories price target lowered to $475 from $535 at BofA - Yahoo Finance
BofA Trims Price Target on IDEXX Laboratories to $475 From $535, Maintains Neutral Rating - marketscreener.com
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? - MSN
Leerink Partners Adjusts Price Target on IDEXX Laboratories to $500 From $525, Maintains Outperform Rating - marketscreener.com
Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating - marketscreener.com
Idexx Laboratories (IDXX): Morgan Stanley Adjusts Price Target, Maintains Overweight Rating | IDXX Stock News - GuruFocus
0.24%
0.46%
자본화:
|
볼륨(24시간):